Infuse Infuse 2 December 2017 | Page 23

The study, published in the New England Journal of Medicine in August this year, is based on 12 years of research that began with the seemingly unrelated goal of seeking “the genetic cause of cardiac, vertebral, and renal defects, among others, in unrelated patients.” The research team had a “Eureka moment” when it connected the NAD-related gene mutation to children with similar combinations of birth defects. While the researchers don’t want to offer false hope to families affected by miscarriage or birth defects, their research “provides strong evidence that vitamin B3 has the potential to prevent these terrible outcomes in some cases.” With this in mind, women are encouraged “to follow the current recommended dose of vitamin B3 (18mg per day) when preparing for pregnancy. iii ” So: how does this study affect the way dietitians should care for pregnant women? Infuse spoke with Prof. Dunwoodie recently to learn just that, and to gain more background on this pioneering study. What was the impetus behind this study? We were working to identify the genetic reason for why babies are born with birth defects – trying to find the gene mutation. We found two gene mutations – HAAO and KYNU – and that pointed us towards the metabolic pathway making NAD. Our whole understanding of the gene